Key result
Progress in Cardiology reviews key advances across cardiovascular genetics, hypertension, and immunology.
Why the study?
New aspects and advances in cardiac disease require presentation focusing on topics of current importance rather than a broad survey.
Provides no new quantitative data to alter management; leaves open need for rigorous trials on genetics and immunology in CVD.
The purpose of the book is to "present new aspects of, and advances in, cardiac disease," without attempts to give a broad survey of the field, emphasizing selection of topics by their current importance. There are 18 distinguished contributors in ten subject chapters, without inclusion of material by the editors. The chapter on "Recent Advances in Genetics of Cardiovascular Disease" by J. Taylor and M. V. Barrow contains interesting general comments on a wide range of familial diseases, including the evidence for inheritance of common entities, ie, hypertension, and those rarer ones identified as having cardiovascular components. Certain chapters, "Genetic" and "Immunological Aspects," are reviews of certain systemic disease entities with involvement of the heart or blood vessels that have varying degrees of importance; often they are inconsequential. Other chapters approach monograph form as complete, elaborately illustrated segments of heart disease, including anatomicphysiologic patterns, recent diagnostic methods, clinical courses, and
No takes yet. Share an insight, caveat, or question.
John J. Sampson (1974) conducted a review in Cardiac disease. The book Progress in Cardiology reviews advances in cardiovascular disease, including genetics, hypertension, and immunology, without presenting new quantitative clinical trial data.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: